FDA Approves Haegarda – First Subcutaneous C1 Esterase Inhibitor for Hereditary Angioedema

Article Link: FDA Approves Haegarda – First Subcutaneous C1 Esterase Inhibitor for Hereditary Angioedema



Source: FDA New Drug Approvals